Impact of Evolocumab on the Effects of Clopidogrel in Patients With High On-Treatment Platelet Reactivity

NCT03096288 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

259

Enrollment

OTHER

Sponsor class

Conditions

Atherosclerotic Cardiovascular Disease

Interventions

DRUG: Evolocumab
OTHER: Placebo

Sponsor

University of Florida

Collaborators

[object Object]